Extracellular matrix and pulmonary hypertension: control of vascular smooth muscle cell contractility - PubMed (original) (raw)
Extracellular matrix and pulmonary hypertension: control of vascular smooth muscle cell contractility
K M Lee et al. Am J Physiol. 1998 Jan.
Abstract
Pulmonary hypertension is characterized by increased vascular resistance due to smooth muscle cell hyper-activity and excess deposition of extracellular matrix (ECM) in the vessel wall. We investigated the possibility that changes in cell-ECM interactions may play an active role in this process by modifying the contractile response of pulmonary vascular smooth muscle (PVSM) cells. Contractility was measured within individual cultured PVSM cells, when resting or stimulated with vasoactive agents, by quantitating changes in stiffness of the cytoskeleton (CSK) using magnetic twisting cytometry (N. Wang, J. P. Butler, and D. E. Ingber. Science 260: 1124-1127, 1993). Control studies confirmed that changes in CSK stiffness closely paralleled alterations in cell contraction and relaxation as measured in response to endothelin-1 (ET-1) and dibutyryl guanosine 3',5'-cyclic monophosphate (cGMP), respectively, in a collagen gel contraction assay. CSK stiffness and contractile tone in cultured PVSM cells increased in direct proportion as the density of fibronectin (FN) coating was raised from 10 to 500 ng/well in 96-well plates. Dibutyryl cGMP had no effect in cells on low FN, although it completely inhibited the FN-dependent increase in CSK stiffness on higher ECM densities. In contrast, ET-1 induced the greatest increase in CSK stiffness on the intermediate FN density (100 ng/well). The reduced sensitivity to ET-1 on high FN was not due to dysfunction of the contractile apparatus nor to changes in protein tyrosine phosphorylation. Taken together, these results show that ECM can modulate PVSM cell contractility and suggest that the changes in ECM observed in hypertensive vessels could play an important role in the etiology of this disease.
Similar articles
- Control of cytoskeletal mechanics by extracellular matrix, cell shape, and mechanical tension.
Wang N, Ingber DE. Wang N, et al. Biophys J. 1994 Jun;66(6):2181-9. doi: 10.1016/S0006-3495(94)81014-8. Biophys J. 1994. PMID: 8075352 Free PMC article. - Extracellular matrix controls myosin light chain phosphorylation and cell contractility through modulation of cell shape and cytoskeletal prestress.
Polte TR, Eichler GS, Wang N, Ingber DE. Polte TR, et al. Am J Physiol Cell Physiol. 2004 Mar;286(3):C518-28. doi: 10.1152/ajpcell.00280.2003. Am J Physiol Cell Physiol. 2004. PMID: 14761883 - Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
Willette RN, Ohlstein EH, Mitchell MP, Sauermelch CF, Beck GR, Luttmann MA, Hay DW. Willette RN, et al. J Pharmacol Exp Ther. 1997 Feb;280(2):695-701. J Pharmacol Exp Ther. 1997. PMID: 9023281 - Endothelial dysfunction and vascular disease - a 30th anniversary update.
Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Vanhoutte PM, et al. Acta Physiol (Oxf). 2017 Jan;219(1):22-96. doi: 10.1111/apha.12646. Epub 2016 Jan 25. Acta Physiol (Oxf). 2017. PMID: 26706498 Review. - Pathobiology of pulmonary hypertension. Extracellular matrix.
Rabinovitch M. Rabinovitch M. Clin Chest Med. 2001 Sep;22(3):433-49, viii. doi: 10.1016/s0272-5231(05)70282-3. Clin Chest Med. 2001. PMID: 11590839 Review.
Cited by
- Huaju Xiaoji Formula Regulates ERS-lncMGC/miRNA to Enhance the Renal Function of Hypertensive Diabetic Mice with Nephropathy.
Zhang Z, Fu X, Zhou F, Zhang D, Xu Y, Fan Z, Wen S, Shao Y, Yao Z, He Y. Zhang Z, et al. J Diabetes Res. 2024 Jan 20;2024:6942156. doi: 10.1155/2024/6942156. eCollection 2024. J Diabetes Res. 2024. PMID: 38282657 Free PMC article. - Quantitative and qualitative analysis of pulmonary arterial hypertension fibrosis using wide-field second harmonic generation microscopy.
Padrez Y, Golubewa L, Kulahava T, Vladimirskaja T, Semenkova G, Adzerikho I, Yatsevich O, Amaegberi N, Karpicz R, Svirko Y, Kuzhir P, Rutkauskas D. Padrez Y, et al. Sci Rep. 2022 May 5;12(1):7330. doi: 10.1038/s41598-022-11473-5. Sci Rep. 2022. PMID: 35513702 Free PMC article. - HIF2A gain-of-function mutation modulates the stiffness of smooth muscle cells and compromises vascular mechanics.
Chan XY, Volkova E, Eoh J, Black R, Fang L, Gorashi R, Song J, Wang J, Elliott MB, Barreto-Ortiz SF, Chen J, Lin BL, Santhanam L, Cheng L, Lee FS, Prchal JT, Gerecht S. Chan XY, et al. iScience. 2021 Mar 2;24(4):102246. doi: 10.1016/j.isci.2021.102246. eCollection 2021 Apr 23. iScience. 2021. PMID: 33796838 Free PMC article. - Potential role of cartilage oligomeric matrix protein in the modulation of pulmonary arterial smooth muscle superoxide by hypoxia.
Yu H, Alruwaili N, Hu B, Kelly MR, Zhang B, Sun D, Wolin MS. Yu H, et al. Am J Physiol Lung Cell Mol Physiol. 2019 Nov 1;317(5):L569-L577. doi: 10.1152/ajplung.00080.2018. Epub 2019 Aug 7. Am J Physiol Lung Cell Mol Physiol. 2019. PMID: 31389735 Free PMC article. - Pulmonary Vascular Platform Models the Effects of Flow and Pressure on Endothelial Dysfunction in BMPR2 Associated Pulmonary Arterial Hypertension.
D'Amico RW, Faley S, Shim HN, Prosser JR, Agrawal V, Bellan LM, West JD. D'Amico RW, et al. Int J Mol Sci. 2018 Aug 29;19(9):2561. doi: 10.3390/ijms19092561. Int J Mol Sci. 2018. PMID: 30158434 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous